-

Law Offices of Frank R. Cruz Encourages SES AI Corporation (SES) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired SES AI Corporation (“SES AI” or the “Company”) (NYSE: SES) securities between January 29, 2025 and March 4, 2026, inclusive (the “Class Period”). SES AI investors have until June 26, 2026 to file a lead plaintiff motion.

Law Offices of Frank R. Cruz Encourages SES AI Corporation (SES) Shareholders To Inquire About Securities Fraud Class Action

Share

IF YOU SUFFERED A LOSS ON YOUR SES AI CORPORATION (SES) INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT.

You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@frankcruzlaw.com, by telephone at (310) 914-5007, or visit our website at www.frankcruzlaw.com.

What Happened?

On December 9, 2025, Wolfpack Research published a report alleging, among other things, that SES AI “promoted an AI product (“Molecular Universe”) that looks . . . like a Chat GPT wrapper to distract from its impending loss of two major customers, Honda and Hyundai, at the end of 2025” and that “[t]o replace this massive hold in their income statement, SES has purchased UZ Energy, a Chinese Energy Storage System (ESS) provider” which “appears to have little American presence.”

Then, on March 4, 2026, SES AI released its fourth quarter and full year 2025 financial results, announcing 2026 revenue guidance below market expectations.

On this news, SES AI’s stock price fell $0.63, or 36.8%, to close at $1.08 per share on March 5, 2026, thereby injuring investors.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) SES AI overstated its business prospects by materially overstating the expected results that could be achieved by deals with companies that have limited or no operations; (2) SES AI created an appearance of revenue by purchasing services in exchange for purchases of Molecular Universe; (3) Contrary to its positive statements regarding growth prospects, SES AI was affected by material logistics constraints in the fourth quarter of 2025 which would materially affect Q4 2025 revenues; (4) the foregoing called into question SES AI’s growth prospects for 2026, which were confirmed due to lower-than expected 2026 revenue guidance; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:

If you purchased SES AI securities, wish to learn more about this action, or have any questions concerning this announcement or your rights or interests with respect to these matters, please click HERE or contact us at:

Law Offices of Frank R. Cruz
2121 Avenue of the Stars, Suite 800
Telephone: 310-914-5007
Email: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Frank R. Cruz
2121 Avenue of the Stars, Suite 800
Telephone: 310-914-5007
Email: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com

The Law Offices of Frank R. Cruz

NYSE:SES

Release Summary
Law Offices of Frank R. Cruz Encourages SES AI Corporation (SES) Shareholders To Inquire About Securities Fraud Class Action
Release Versions

Contacts

Law Offices of Frank R. Cruz
2121 Avenue of the Stars, Suite 800
Telephone: 310-914-5007
Email: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com

Social Media Profiles
More News From The Law Offices of Frank R. Cruz

Deadline Soon: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming May 4, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between July 23, 2025 and February 3, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON BOSTON SCIENTIFIC CORPORATION (BSX), CLICK HERE TO...

Deadline Soon: Apollo Global Management, Inc. (APO) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming May 1, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Apollo Global Management, Inc. ("Apollo" or the "Company") (NYSE: APO) securities between May 10, 2021 and February 21, 2026 inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON APOLLO GLOBAL MANAGEMENT, INC. (APO), CLICK HERE TO PARTICIPA...

Securities Fraud Investigation Into Regencell Bioscience Holdings Limited (RGC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON REGENCELL BIOSCIENCE HOLDINGS LIMITED (RGC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On October 31, 2025, Regencell di...
Back to Newsroom